ArticleTherapeutic advances in medical oncology2023
Why the length of recurrence-free survival or 'lead-times' can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J,
Steven SorscherPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.